southern african hiv clinicians society's strategic imperatives
DESCRIPTION
Southern African HIV Clinicians Society's strategic imperatives. Dr Francesca Conradie President of the SAHCS. WHO ARE WE?. Non-profit membership organisation of HIV health care workers Formed in 1997 by Prof Des Martin to help coordinate response to HIV/AIDS epidemic - PowerPoint PPT PresentationTRANSCRIPT
Southern African HIV Clinicians Society's strategic imperatives
Dr Francesca Conradie President of the SAHCS
Non-profit membership organisation of HIV health care workers
Formed in 1997 by Prof Des Martin to help coordinate response to HIV/AIDS epidemic
Governed by an eight member elected Board of Directors
WHO ARE WE?
Society membership is inclusive of all health care workers in HIV: doctors, related professionals, nurses and 2012 greater focus on lay HCWs as well
Approximately 3 700 members 58% doctors; 50% public sector 50% private sector28% nurse; 5% pharmacist85% South African, remaining largely Southern African (Botswana and Namibia)37% reside in Gauteng; ~15% KZN, Western Cape and Eastern Cape each Paediatrics is the largest reported specialty
WHO DO WE SERVE?
To promote quality comprehensive, evidence-based HIV healthcare in Southern Africa
MISSION & OBJECTIVES
Objectives:To partner with governments to implement optimal HIV programmes and policies
To foster evidence-based HIV related education for healthcare workers
To produce evidence-based guidelines
To facilitate interactions amongst HIV healthcare workers to optimise patient care
To expand access to the activities of the Society
To advocate for the best possible HIV treatment, care and prevention
To improve TB diagnosis, care and prevention within the context of the HIV epidemic
MISSION & OBJECTIVES
Presented at the TB Conference 2012By Dr. Francesca Conradie
To provide high quality, evidence-based information and resources to HIV health care workers
“Voice of reason”
Focus more resources to nurses (e.g. HIV Nursing Matters, clinical tip, nurse training, developing capacity, supporting health systems strengthening, leadership hubs)
To develop regional foot-print
To run first clinical conference focusing on HIV medicine in Southern Africa
WHAT IS OUR MANDATE 2012?
Presented at the TB Conference 2012By Dr. Francesca Conradie
Southern African Journal of HIV Medicine
HIV Nursing Matters magazine
Clinical practice guidelines
Website: clinical case study programme & searchable provider directory
SMS clinical tips
Limited Bursaries and educational opportunities
Bi-annual clinical conference
CPD-accredited branch meetings & Leadership Hubs
PROGRAMMES & ACTIVITIES
NATIONAL HIV PREVALENCE TRENDS (1990 – 2010)
SANDOH. National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa. 2011
What has been achieved so far?
• Treatment • Prevention• Then Treatment as prevention?
Numbers• 1.8 million on antiretroviral therapy in public
sector• +/- 200 000 in private sector• Successful program• Reduction in mother to child transmission
3.5%• Increase in life expectancy
Prevention
• Generally not successful• Drivers of the epidemic different in different places,
ages etc• Behaviour difficult to change• Very high awareness of HIV in South Africa in general. • Voluntary medical male circumcision.
Prevalence by Gender
Treatment as prevention
• Pivotal study done, HPTN 052.• Discordant couple- one HIV+ and one HIV-• One arm was given antiretroviral therapy at a
high CD4+ and one arm at CD4+ of 250.
Total HIV-1 Transmission Events: 39
HPTN 052: HIV-1 Transmission
Immediate Arm4
Delayed Arm
35
p < 0.0001
Total HIV-1 Transmission Events: 39
HPTN 052: HIV-1 Transmission
Linked Transmissions: 28
Unlinked or TBD Transmissions: 11
p < 0.001
Immediate Arm: 1
Delayed Arm: 27
• 18/28 (64%) transmissions from infected participants with CD4 >350 cells/mm3
• 23/28 (82%) transmissions in sub-Saharan Africa
• 18/28 (64%) transmissions from female to male partners
Treatment as prevention
• Pre- exposure prophylaxis (PrEP)– Truvada– For both heterosexual and homosexual transmission. – Recently approved by the FDA
• Microbicide• - CAPRISA 004 (UKZN)
Public enemy No.1
• TB
Incidence in SA (https://extranet.who.int/sree/Reports?op=Replet&name=
%2FWHO_HQ_Reports%2FG2%2FPROD%2FEXT%2FTBCountryProfile&ISO2=ZA&outtype=html
The easy answer.
The tough answers• Policy reasons• Diagnostics • Treatment • Research
Diagnostics
Diagnostics
HIV
Diagnostics
Time to diagnosis
Microscopy
• Acid fast bacteria visualized on a slide may represent M. tuberculosis or non-tuberculous mycobacteria
Gene Xpert MTB/RIF
• Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance
National Strategic Plan for HIV, TB and STIs
• Very ambitious document www.doh.gov.za/docs/stratdocs/2012/NSPsum.pdf• Know you epidemic• Getting to zero
What are the good things?
• Political Commitment• Dark Mbeki days are over• Minister Aaron Motsaeledi
What are the challenges?
• Changing /decrease in international funding• Uncertainty about PEPFAR, Global Fund• Disbanding of SANAC and the re-formation.• Poorly functioning health care system• Lack of accountability between provincial and
national authorities
Role of the SAHCS
• Brains trust– Training– Guideline development – Taking new research findings and turning them
into policy
• Advocacy– Keeping government on track